Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03645590 · ClinicalTrials.gov registry record · NA
Stroke Ready - Optimizing Acute Stroke Care
A NA study of Stroke and Stroke, Acute, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 5,970
- Enrollment target
- 1
- Study location
NCT03645590: Completed NA study of Stroke and Stroke, Acute, sponsored by University of Michigan.
NCT03645590 is a NA study of Stroke and Stroke, Acute that has completed, run by University of Michigan. The registered enrollment target is 5,970 participants, below the 12,003-participant average among 454 other Stroke trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03645590, a NA study of Stroke and Stroke, Acute, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,970 participants
- Enrollment target
- 1
- Study location
Study Summary
The study aims to increase acute stroke treatment rates in Flint, Michigan through a two-pronged approach of hospital and community level interventions. It also aims to inform future stroke preparedness interventions by exploring the relative importance of hospital optimization and community interventions.
Primary Outcome
Proportion of Tissue Plasminogen Activator (tPA) treatment utilization among ischemic stroke and TIA patients in pre vs. post intervention periods in all Genesee county hospitals. This is a distinct group of county-wide patients who may or may not include any individuals who received the workshop intervention.
Conditions Studied
Interventions
- BEHAVIORAL Stroke Ready
Study Locations (1)
Michigan
- Flint Communiy - Flint
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,970 participants |
| Start Date | 2018-06-20 |
| Est. Completion | 2021-03-31 |
| Phase | NA |
What the finished NCT03645590 record still lists
NCT03645590 is an interventional study that assigns participants to a tested intervention. Its 5,970 participants enrollment target places it among the larger protocols in the corpus, below the 12,003-participant average among 454 other Stroke trials with a reported enrollment target (50% lower).
The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Stroke Ready is the first listed.
NCT03645590 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03645590 about?
NCT03645590 is a clinical study titled "Stroke Ready - Optimizing Acute Stroke Care". The study aims to increase acute stroke treatment rates in Flint, Michigan through a two-pronged approach of hospital and community level interventions. It also aims to inform future stroke preparedness interventions by exploring the relative importance of hospital optimization and community interve...
What is the current status of trial NCT03645590?
This trial is currently completed. It is a NA study. The enrollment target is 5,970 participants. The study started on 2018-06-20. Estimated completion is 2021-03-31.
What conditions does trial NCT03645590 study?
This clinical trial studies the following conditions: Stroke, Stroke, Acute.
What interventions are being tested in trial NCT03645590?
The interventions under investigation include: Stroke Ready (BEHAVIORAL).
Who is sponsoring clinical trial NCT03645590?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03645590 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03645590's enrollment target sits among peer trials
5,970 13th of 454 higher than 442 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06192511 · 5,980 participants · NA
Implementing a Novel Consent Process for Biospecimen Research After Newborn Screening
- NCT03959085 · 5,951 participants · Phase 3
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- NCT00005095 · 6,000 participants
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
- NCT00280202 · 6,000 participants
Detection of Genetic Markers of Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI